These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7856680)

  • 1. Safety of metronidazole in pregnancy: a meta-analysis.
    Burtin P; Taddio A; Ariburnu O; Einarson TR; Koren G
    Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 1):525-9. PubMed ID: 7856680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is metronidazole teratogenic? A meta-analysis.
    Caro-Patón T; Carvajal A; Martin de Diego I; Martin-Arias LH; Alvarez Requejo A; Rodríguez Pinilla E
    Br J Clin Pharmacol; 1997 Aug; 44(2):179-82. PubMed ID: 9278206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.
    Cassina M; Donà M; Di Gianantonio E; Litta P; Clementi M
    Hum Reprod Update; 2014; 20(5):656-69. PubMed ID: 24861556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
    Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
    Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected High Rates of Persistent Trichomonas vaginalis Infection in a Retrospective Cohort of Treated Pregnant Women.
    Lazenby GB; Thompson L; Powell AM; Soper DE
    Sex Transm Dis; 2019 Jan; 46(1):2-8. PubMed ID: 30067546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection.
    Klebanoff MA; Carey JC; Hauth JC; Hillier SL; Nugent RP; Thom EA; Ernest JM; Heine RP; Wapner RJ; Trout W; Moawad A; Leveno KJ; Miodovnik M; Sibai BM; Van Dorsten JP; Dombrowski MP; O'Sullivan MJ; Varner M; Langer O; McNellis D; Roberts JM;
    N Engl J Med; 2001 Aug; 345(7):487-93. PubMed ID: 11519502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer-generation antiepileptic drugs and the risk of major birth defects.
    Mølgaard-Nielsen D; Hviid A
    JAMA; 2011 May; 305(19):1996-2002. PubMed ID: 21586715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population based case-control teratologic study of oral metronidazole treatment during pregnancy.
    Czeizel AE; Rockenbauer M
    Br J Obstet Gynaecol; 1998 Mar; 105(3):322-7. PubMed ID: 9532994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
    Seto A; Einarson T; Koren G
    Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis.
    Ziv A; Masarwa R; Perlman A; Ziv D; Matok I
    Pharm Res; 2018 Mar; 35(5):109. PubMed ID: 29582196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects.
    Pasternak B; Hviid A
    JAMA; 2010 Aug; 304(8):859-66. PubMed ID: 20736469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
    Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
    Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal use of metronidazole and birth defects: no association.
    Piper JM; Mitchel EF; Ray WA
    Obstet Gynecol; 1993 Sep; 82(3):348-52. PubMed ID: 8355932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester anesthesia exposure and the risk of central nervous system defects: a population-based case-control study.
    Sylvester GC; Khoury MJ; Lu X; Erickson JD
    Am J Public Health; 1994 Nov; 84(11):1757-60. PubMed ID: 7977913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of metronidazole during pregnancy.
    Coustan DR
    Pediatr Infect Dis J; 1999 Jan; 18(1):79. PubMed ID: 9951994
    [No Abstract]   [Full Text] [Related]  

  • 18. Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.
    Thomseth V; Cejvanovic V; Jimenez-Solem E; Poulsen HE; Utheim TP; Andersen JT
    Acta Ophthalmol; 2019 Aug; 97(5):505-509. PubMed ID: 30479070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.